03690nam 2200673Ia 450 991014055620332120230725023704.01-118-04355-31-282-65368-797866126536810-470-64046-40-470-64045-6(CKB)2670000000031669(EBL)547169(OCoLC)654805703(SSID)ssj0000412841(PQKBManifestationID)11913158(PQKBTitleCode)TC0000412841(PQKBWorkID)10388453(PQKB)10945061(MiAaPQ)EBC547169(Au-PeEL)EBL547169(CaPaEBR)ebr10419149(CaONFJC)MIL265368(EXLCZ)99267000000003166920100203d2010 uy 0engur|n|---|||||txtccrBiofilm eradication and prevention[electronic resource] a pharmaceutical approach to medical device infections /Tamilvanan ShunmugaperumalOxford Wiley-Blackwell20101 online resource (448 p.)Description based upon print version of record.0-470-47996-5 Includes bibliographical references and index.BIOFILM ERADICATION AND PREVENTION; CONTENTS; PREFACE; ACKNOWLEDGMENTS; PART I. DEVELOPMENT AND CHARACTERIZATION OF BIOFILMS; 1. INTRODUCTION AND OVERVIEW OF BIOFILM; 2. RATIONALE FOR BIOFILM ERADICATION FROM MODERN MEDICAL DEVICES; 3. PATHOGENESIS OF DEVICE-RELATED NOSOCOMIAL INFECTIONS; 4. BIOFILM RESISTANCE-TOLERANCE TO CONVENTIONAL ANTIMICROBIAL AGENTS; 5. ANALYTICAL TECHNIQUES USEFUL TO STUDY BIOFILMS; PART II. BIOFILM-RELATED INFECTIONS IN VARIOUS HUMAN ORGANS (NONDEVICE-RELATED CHRONIC INFECTIONS); 6. BIOFILM-RELATED INFECTIONS IN OPHTHALMOLOGY7. BIOFILM-RELATED INFECTIONS IN THE ORAL CAVITY8. IMPLICATIONS OF BIOFILM FORMATION IN CHRONIC WOUNDS AND IN CYSTIC FIBROSIS; PART III. DRUG DELIVERY CARRIERS TO ERADICATE BIOFILM FORMATION ON MEDICAL DEVICES; 9. STRATEGIES FOR PREVENTION OF DEVICE-RELATED NOSOCOMIAL INFECTIONS; 10. LIPOSOMES AS DRUG DELIVERY CARRIERS TO BIOFILMS; 11. POLYMER-BASED ANTIMICROBIAL DELIVERY CARRIERS; INDEXBiofilm Eradication and Preventions presents the basics of biofilm formation on medical devices, diseases related to this formation, and approaches pharmaceutical researchers need to take to limit this problem. Split into three parts, the first deals with the development and characterization of biofilm on the surfaces of implanted or inserted medical devices. Questions as to why biofilms form over medical device surfaces and what triggers biofilm formation are addressed. In the second section, the author discusses biofilm-mediated chronic infections occurred in various organs (eyes, mouMedical instruments and apparatusMicrobiologyBiofilmsMedical instruments and apparatusSterilizationAnti-infective agentsTherapeutic useDrug carriers (Pharmacy)Therapeutic useMedical instruments and apparatusMicrobiology.Biofilms.Medical instruments and apparatusSterilization.Anti-infective agentsTherapeutic use.Drug carriers (Pharmacy)Therapeutic use.610.284Shunmugaperumal Tamilvanan868419MiAaPQMiAaPQMiAaPQBOOK9910140556203321Biofilm eradication and prevention1938547UNINA